|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Spruit HE, Langenberg JP, Trap HC, van der Wiel HJ, Helmich RB, van Helden HP, Benschop HP. 2000. Intravenous and inhalation toxicokinetics of sarin stereoisomers in atropinized guinea pigs. Toxicology and Applied Pharmacology 169(3):249–254. Stewart CE, Sullivan J Jr. 1992. Military munitions and antipersonnel agents. In: Sullivan JB Jr, Krieger G, eds. Hazardous Materials Toxicology: Clinical Principles of Environmental Health. Baltimore, MD: Williams & Wilkins. Pp. 986–1014. Tørnes JA. 1996. Identification of alkyl methylphosphonic acids by thermospray tandem mass spectrometry. Rapid Communications in Mass Spectrometry 10:878–882. Tripathi HL, Dewey WL. 1989. Comparison of the effects of diisopropylfluorophosphate, sarin, soman, and tabun on toxicity and brain acetylcholinesterase activity in mice. Journal of Toxicology and Environmental Health 26(4):437–446. Willems JL, Palate BM, Vranken MA, De Bisschop HC. 1983. Proceedings of the International Symposium on Protection against Chemical Warfare Agents. Umea, Sweden: National Defense Research Institute. Pp. 95–100. Yamada Y, Takatori T, Nagao M, Iwase H, Kuroda N, Yanagida J, Shinozuka T. 2001. Expression of paraoxonase isoform did not confer protection from acute sarin poisoning in the Tokyo subway terrorist attack. International Journal of Legal Medicine 115(2):82–84. Yamasaki Y, Sakamoto K, Watada H, Kajimoto Y, Hori M. 1997. The Arg192 isoform of paraoxonase with low sarin-hydrolyzing activity is dominant in the Japanese. Human Genetics 101(1):67–68.
|
||||||||||||||||
